KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

标题
KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
作者
关键词
KRAS, NSCLC, Checkpoint inhibitors
出版物
CANCER TREATMENT REVIEWS
Volume 85, Issue -, Pages 101978
出版商
Elsevier BV
发表日期
2020-02-08
DOI
10.1016/j.ctrv.2020.101978

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation